Dr. Roberto Marchioli, MD - Quintiles - Medical Director

Dr. Roberto Marchioli

MD

Quintiles

Medical Director

Pescara | Italy

Main Specialties: Internal Medicine

Additional Specialties: Internal medicine

Dr. Roberto Marchioli, MD - Quintiles - Medical Director

Dr. Roberto Marchioli

MD

Introduction

Primary Affiliation: Quintiles - Pescara , Italy

Specialties:

Additional Specialties:

Publications

82Publications

3333Reads

-Profile Views

2127PubMed Central Citations

Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosis.

J Am Coll Cardiol 2014 Jul;64(3):319-27

Institute of Cardiology, "G. D'Annunzio" University, Chieti, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2014.03.049DOI Listing
July 2014
62 Reads
19 Citations
16.503 Impact Factor

Reduction of albumin urinary excretion is associated with reduced cardiovascular events in hypertensive and/or diabetic patients. A meta-regression analysis of 32 randomized trials.

Int J Cardiol 2014 Mar 24;172(2):403-10. Epub 2014 Jan 24.

Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2014.01.065DOI Listing
March 2014
31 Reads
6 Citations
4.040 Impact Factor

n-3 PUFAs in cardiovascular disease.

Int J Cardiol 2013 Dec 6;170(2 Suppl 1):S33-8. Epub 2013 Sep 6.

Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti, Italy; Coronary Care Unit, Cardiologic Department, 'S.Pio' Hospital Vasto, Chieti, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2013.06.042DOI Listing
December 2013
20 Reads
4 Citations
4.040 Impact Factor

n-3 polyunsaturated fatty acids and atrial fibrillation in patients with chronic heart failure: the GISSI-HF trial.

Eur J Heart Fail 2013 Nov 9;15(11):1289-95. Epub 2013 Jul 9.

Cardiovascular Department, 'Ospedali Riuniti' and University of Trieste, Trieste, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurjhf/hft103DOI Listing
November 2013
46 Reads
4 Citations
6.530 Impact Factor

Uric acid: a cardiovascular risk factor in patients with recent myocardial infarction.

Int J Cardiol 2013 Jul 20;167(1):262-9. Epub 2012 Jan 20.

Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2011.12.110DOI Listing
July 2013
9 Reads
3 Citations
4.040 Impact Factor

n-3 fatty acids in patients with multiple cardiovascular risk factors.

N Engl J Med 2013 05;368(19):1800-8

Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1205409DOI Listing
May 2013
57 Reads
74 Citations
55.873 Impact Factor

Treatment target in polycythemia vera.

N Engl J Med 2013 04;368(16):1556

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1301262DOI Listing
April 2013
27 Reads
2 Citations
55.873 Impact Factor

Wine consumption and risk of cardiovascular events after myocardial infarction: results from the GISSI-Prevenzione trial.

Int J Cardiol 2013 Mar 6;163(3):282-287. Epub 2011 Jul 6.

Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2011.06.053DOI Listing
March 2013
52 Reads
6 Citations
4.040 Impact Factor

Fish oil vs olive oil for postoperative atrial fibrillation--reply.

JAMA 2013 Mar;309(9):871-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2013.673DOI Listing
March 2013
27 Reads
35.290 Impact Factor

Bedside monitoring of antiplatelet therapy for coronary stenting.

N Engl J Med 2013 02;368(9):871

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1300053DOI Listing
February 2013
11 Reads
55.873 Impact Factor

Polycythemia vera: gender-related phenotypic differences.

Intern Emerg Med 2012 Dec 10;7(6):509-15. Epub 2011 Jun 10.

Institute of Internal Medicine and Geriatrics, Haemostasis Research Center, Catholic University School of Medicine, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11739-011-0634-3DOI Listing
December 2012
38 Reads
3 Citations
2.624 Impact Factor

Autonomic markers and cardiovascular and arrhythmic events in heart failure patients: still a place in prognostication? Data from the GISSI-HF trial.

Eur J Heart Fail 2012 Dec 30;14(12):1410-9. Epub 2012 Jul 30.

Divisione di Cardiologia, e Bioingegneria, Fondazione Salvatore Maugeri, IRCCS, Istituto Scientifico di Montescano, Montescano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurjhf/hfs126DOI Listing
December 2012
88 Reads
8 Citations
6.530 Impact Factor

Why Do We Still Need Large Scale Clinical Trial: The Case of n-3 PUFA.

Front Physiol 2012 28;3:202. Epub 2012 Jun 28.

Laboratory of Clinical Epidemiology of Cardiovascular Disease, Consorzio Mario Negri Sud Chieti, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fphys.2012.00202DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3385353PMC
October 2012
15 Reads

The CYTO-PV: A Large-Scale Trial Testing the Intensity of CYTOreductive Therapy to Prevent Cardiovascular Events in Patients with Polycythemia Vera.

Thrombosis 2011 17;2011:794240. Epub 2011 May 17.

CYTO-PV Coordinating Center, Consorzio Mario Negri Sud, Via Nazionale, 66030 Santa Maria Imbaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2011/794240DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200258PMC
November 2011
51 Reads
9 Citations

[The Alpha Omega study].

G Ital Cardiol (Rome) 2011 Jul-Aug;12(7-8):469-73

Dipartimento di Medicina, Universita degli Studi Federico II, Napoli, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/915.10072DOI Listing
September 2011
33 Reads

The ω-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation trial--rationale and design.

Am Heart J 2011 Jul 12;162(1):56-63.e3. Epub 2011 Jun 12.

Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2011.03.035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3134828PMC
July 2011
16 Reads
11 Citations
4.463 Impact Factor

Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial.

Eur J Heart Fail 2010 Dec 16;12(12):1345-53. Epub 2010 Oct 16.

Divisione di Cardiologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurjhf/hfq172DOI Listing
December 2010
45 Reads
15 Citations
6.530 Impact Factor

[Memorandum for the management of clinical trials].

Assist Inferm Ric 2010 Jan-Mar;29(1):26-40

Unità di Gestione e Monitoraggio della Ricerca Clinica - Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti.

View Article

Download full-text PDF

Source
August 2010
50 Reads

Uses and benefits of omega-3 ethyl esters in patients with cardiovascular disease.

J Multidiscip Healthc 2010 Jul 7;3:79-96. Epub 2010 Jul 7.

Laboratory of Clinical Epidemiology of Cardiovascular Disease, Consorzio Mario Negri Sud, Chieti, Italy.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004594PMC
http://dx.doi.org/10.2147/jmdh.s4743DOI Listing
July 2010
28 Reads
1 Citation

The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial.

Eur J Heart Fail 2010 Apr 22;12(4):338-47. Epub 2010 Jan 22.

Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche Mario Negri, via La Masa 19, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurjhf/hfp206DOI Listing
April 2010
38 Reads
20 Citations
6.530 Impact Factor

Systematic review of trials using vasodilators in pulmonary arterial hypertension: why a new approach is needed.

Am Heart J 2010 Feb;159(2):245-57

Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Via Nazionale 8, Santa Maria Imbaro, Chieti, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2009.11.028DOI Listing
February 2010
28 Reads
16 Citations
4.463 Impact Factor

Cholesterol-lowering interventions and stroke: insights from a meta-analysis of randomized controlled trials.

J Am Coll Cardiol 2010 Jan;55(3):198-211

Institute of Cardiology and University Cardiology Division, G d'Annunzio University, Chieti, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2009.07.062DOI Listing
January 2010
30 Reads
16 Citations
16.503 Impact Factor

Omega-3 fatty acids and heart failure.

Curr Atheroscler Rep 2009 Nov;11(6):440-7

Consorzio Mario Negri Sud, Via Nazionale, Santa Maria Imbaro, Italy.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s11883-009-0066
Web Search
http://dx.doi.org/10.1007/s11883-009-0066-yDOI Listing
November 2009
19 Reads
6 Citations
3.420 Impact Factor

Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial.

Eur Heart J 2009 Oct 30;30(19):2327-36. Epub 2009 Aug 30.

GISSI-HF Coordinating Center, ANMCO Research Center, Via La Marmora, 34, 50121 Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehp357DOI Listing
October 2009
45 Reads
21 Citations
15.203 Impact Factor

[Coffee and cardiovascular disease risk: yin and yang].

Recenti Prog Med 2008 Nov;99(11):533-7

Laboratorio di Epidemiologia clinica delle Malattie cardiovascolari, Consorzio Mario Negri Sud, Santa Maria Imbaro.

View Article

Download full-text PDF

Source
November 2008
6 Reads

Omega-3 fatty acids for cardioprotection.

Mayo Clin Proc 2008 Mar;83(3):324-32

Mid America Heart Institute and University of Missouri-Kansas City, 4330 Wornall Road, Kansas City, MO 64111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4065/83.3.324DOI Listing
March 2008
9 Reads
39 Citations
6.262 Impact Factor

Meta-analysis of effect of statin treatment on risk of sudden death.

Am J Cardiol 2007 Dec 24;100(11):1644-50. Epub 2007 Oct 24.

Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2007.07.015DOI Listing
December 2007
46 Reads
10 Citations
3.280 Impact Factor

Analysis of the benefits of a Mediterranean diet in the GISSI-Prevenzione study: a case study in imputation of missing values from repeated measurements.

Eur J Epidemiol 2006 ;21(1):15-24

The George Institute for International Health, University of Sydney, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10654-005-5086-5DOI Listing
September 2007
23 Reads
2 Citations
5.340 Impact Factor

Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors.

Lancet 2007 Aug;370(9588):667-75

Department of Medicine, Harvard Medical School and Harvard School of Public Health, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(07)61343-9DOI Listing
August 2007
44 Reads
33 Citations
45.220 Impact Factor

Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study.

Blood 2007 Aug 17;110(4):1178-83. Epub 2007 Apr 17.

Divisione di Ematologia, Ospedali Riuniti, Bergamo, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-01-066043DOI Listing
August 2007
43 Reads
16 Citations
10.452 Impact Factor

A meta-analysis of trials of pulmonary hypertension: a clinical condition looking for drugs and research methodology.

Am Heart J 2007 Jun;153(6):1037-47

Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2007.02.037DOI Listing
June 2007
6 Reads
46 Citations
4.463 Impact Factor

Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera.

Blood 2007 Mar 14;109(6):2446-52. Epub 2006 Nov 14.

Catholic University School of Medicine, Institute of Internal Medicine and Geriatrics, Haemostasis Research Center, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-08-042515DOI Listing
March 2007
48 Reads
46 Citations
10.452 Impact Factor

The haematocrit and platelet target in polycythemia vera.

Br J Haematol 2007 Jan 8;136(2):249-59. Epub 2006 Dec 8.

Department of Medicine and Aging, School of Medicine, and Aging Research Centre, Ce S I, Gabriele D'Annunzio University Foundation, Chieti-Pescara, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2006.06430.xDOI Listing
January 2007
47 Reads
16 Citations
4.711 Impact Factor

Vitamin E increases the risk of developing heart failure after myocardial infarction: Results from the GISSI-Prevenzione trial.

J Cardiovasc Med (Hagerstown) 2006 May;7(5):347-50

Laboratory of Clinical Epidemiology of Cardiovascular Disease, Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S. Maria Imbaro (CH), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2459/01.JCM.0000223257.09062.17DOI Listing
May 2006
34 Reads
23 Citations
1.410 Impact Factor

[Determinants of late-onset heart failure in myocardial infarction survivors: GISSI Prevenzione trial results].

Rev Esp Cardiol 2005 Nov;58(11):1266-72

Departamento de Farmacología Clínica y Epidemiología, Consorzio Mario Negri Sud, Santa Maria Imbaro, Italia.

View Article

Download full-text PDF

Source
November 2005
15 Reads
1 Citation
3.792 Impact Factor

Clinical trials in myeloproliferative disorders: looking forward.

Semin Hematol 2005 Oct;42(4):259-65

Laboratory of Epidemiology of Cardiovascular Disease, Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Via Nazionale 8, 66030 Santa Maria Imbaro, Chieti, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2005.05.021DOI Listing
October 2005
21 Reads
1 Citation
3.274 Impact Factor

Metabolic syndrome and risk of cardiovascular events after myocardial infarction.

J Am Coll Cardiol 2005 Jul;46(2):277-83

Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2005.03.062DOI Listing
July 2005
20 Reads
27 Citations
16.503 Impact Factor

Vascular and neoplastic risk in a large cohort of patients with polycythemia vera.

J Clin Oncol 2005 Apr 14;23(10):2224-32. Epub 2005 Feb 14.

European Collaboration on Low-Dose Aspirin in Polycythemia Vera Coordinating Centre, Consorzio Mario Negri Sud, Via Nazionale, 66030 Santa Maria Imbaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.07.062DOI Listing
April 2005
52 Reads
76 Citations
18.430 Impact Factor

[Chart of the post myocardial infarction risk: results of GISSI-Prevention].

Ital Heart J 2004 Nov;5 Suppl 8:86S-90S; discussion 115S-121S

Laboratorio di Epidemiologia delle Malattie Cardiovascolari, Dipartimento di Farmacologia Clinica ed Epidemiologia, Consorzio Mario Negri Sud, S. Maria Imbaro, (CH).

View Article

Download full-text PDF

Source
November 2004
25 Reads

Chronic myeloproliferative disorders.

Hematology Am Soc Hematol Educ Program 2003 :200-24

Johns Hopkins University School of Medicine, Department of Medicine, Baltimore, MD 21205-2109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2003.1.200DOI Listing
September 2004
102 Reads
8 Citations

Early modifications of fatty acid composition in plasma phospholipids, platelets and mononucleates of healthy volunteers after low doses of n-3 polyunsaturated fatty acids.

Eur J Clin Pharmacol 2004 May 7;60(3):183-90. Epub 2004 Apr 7.

Department of Molecular Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri, Via Eritrea 62, 20157 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-004-0758-8DOI Listing
May 2004
29 Reads
18 Citations
2.970 Impact Factor

Efficacy and safety of low-dose aspirin in polycythemia vera.

N Engl J Med 2004 Jan;350(2):114-24

Catholic University School of Medicine, Rome, Italy.

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/abs/10.1056/NEJMoa035572
Publisher Site
http://dx.doi.org/10.1056/NEJMoa035572DOI Listing
January 2004
52 Reads
69 Citations
55.873 Impact Factor

Plasma protein oxidation is associated with an increase of procoagulant markers causing an imbalance between pro- and anticoagulant pathways in healthy subjects.

Thromb Haemost 2002 Jan;87(1):58-67

Hemostasis Research Center, Department of Internal Medicine, Catholic University School of Medicine, Rome, Italy.

View Article

Download full-text PDF

Source
January 2002
19 Reads
1 Citation
4.984 Impact Factor

Top co-authors

Gianni Tognoni
Gianni Tognoni

Department of Clinical Pharmacology and Epidemiology

43
Luigi Tavazzi
Luigi Tavazzi

Maria Cecilia Hospital

35
Giacomo Levantesi
Giacomo Levantesi

Laboratory of Clinical Epidemiology of Cardiovascular Disease

19
Tiziano Barbui
Tiziano Barbui

University of Florence

16
Roberto Latini
Roberto Latini

Department of Cardiovascular Research

16
Aldo P Maggioni
Aldo P Maggioni

ANMCO Research Center

14
Guido Finazzi
Guido Finazzi

University of Bologna

14
Gian Luigi Nicolosi
Gian Luigi Nicolosi

Policlinico san Giorgio

13
Maria Grazia Franzosi
Maria Grazia Franzosi

Population Health Research Institute

12
Rosa Maria Marfisi
Rosa Maria Marfisi

Department of Clinical Pharmacology and Epidemiology

12